Le Lézard
Classified in: Health
Subjects: AWD, PER, CSR, DIS, DEI

Quest Diagnostics Named a 'Best Place to Work for Disability Inclusion' for Sixth Consecutive Year


SECAUCUS, N.J., July 13, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2023 Disability Equality Index® (DEI) Best Places to Work for Disability Inclusion by Disability: IN and the American Association of People with Disabilities (AAPD).

The Disability Equality Index (DEI) is a comprehensive benchmarking tool that helps companies build a roadmap of measurable, tangible actions that they can take to achieve disability inclusion and equality.

"We are honored to be named a 'Best Place to Work for Disability Inclusion' for the sixth consecutive year," said Cecilia McKenney, Quest's Chief Human Resources Officer. "Achieving our purpose of 'Working together to create a healthier world, one life at a time' can only be accomplished if we continue to advance inclusion for people with disabilities. Together with the valuable insights and advocacy of our DiverseAbilities Employee Business Network, we are fostering a more inclusive and caring work environment while enriching the lives of those we serve."

Quest launched the DiverseAbilities Employee Business Network (EBN) in 2016 as part of its commitment to empowering people with disabilities. The group, which includes over 350 employees, is placing a strong emphasis on neurodiversity, cancer support, and accessibility for both employees and the customers.

"Giving all people, including those with disabilities, the opportunity to access and take action with the information we provide is critical to our success as a company," said Pete Reiser, Executive Director, Digital Program Management, and co-lead of the DiverseAbilities EBN, whose debilitating spine injury several years ago gives him a firsthand understanding of the importance of disability inclusion. "Expanding accessibility for employees and customers with disabilities is good for our company." 

This is the sixth consecutive year Quest has been recognized by the DEI, which is acknowledged as the most comprehensive benchmarking tool to measure disability workplace inclusion. The 2023 DEI measured: Culture & Leadership; Enterprise-Wide Access; Employment Practices; Community Engagement; Supplier Diversity; and Non-U.S. Operations.

Read more about Quest's award-winning culture on the company's ESG Resources page. Find the full 2023 Disability Equality Index® here.

About Quest Diagnostics 
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in?the?United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.?www.QuestDiagnostics.com

About the Disability Equality Index®
The Disability Equality Index (DEI) is a comprehensive benchmarking tool that helps companies build a roadmap of measurable, tangible actions that they can take to achieve disability inclusion and equality. Each company receives a score, on a scale of zero (0) to 100, with those earning 80 and above recognized as a "Best Place to Work for Disability Inclusion".

The DEI is a joint initiative of the American Association of People with Disabilities (AAPD), the nation's largest disability rights organization, and Disability:IN, the global business disability inclusion network, to collectively advance the inclusion of people with disabilities. The organizations are complementary and bring unique strengths that make the project relevant and credible to corporations and the disability community. The tool was developed by the DEI Advisory Committee, a diverse group of business leaders, policy experts, and disability advocates. Learn more at: www.DisabilityEqualityIndex.org.

SOURCE Quest Diagnostics


These press releases may also interest you

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

4 mai 2024
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

4 mai 2024
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...



News published on and distributed by: